Skip to main content

Carbamazepine

NDC 62559-484 · ANI Pharmaceuticals, Inc.

Generic namecarbamazepine
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
Active ingredient(s)CARBAMAZEPINE
Strength100 mg/1
Pharmacologic classCytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
Marketing categoryANDA

Packages

62559-484-12 — 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-484-12)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60687-594 — CARBAMAZEPINE, 62135-802 — Carbamazepine, 62135-867 — Carbamazepine, 62135-927 — Carbamazepine ER, 62135-928 — Carbamazepine ER, 62135-930 — Carbamazepine ER, 62332-420 — Carbamazepine, 62332-421 — Carbamazepine, 62332-422 — Carbamazepine, 62332-731 — CARBAMAZEPINE, 62559-485 — carbamazepine, 62559-486 — carbamazepine, 63629-5914 — Carbamazepine, 63629-8753 — Carbamazepine, 67046-0707 — Carbamazepine, 67046-0753 — CARBAMAZEPINE, 67046-1455 — carbamazepine, 67046-1534 — Carbamazepine, 67046-1558 — carbamazepine, 67046-1559 — carbamazepine, +134 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T42.1X1 — Poisoning by iminostilbenes, accidental (unintentional), T42.1X2 — Poisoning by iminostilbenes, intentional self-harm, T42.1X3 — Poisoning by iminostilbenes, assault, T42.1X4 — Poisoning by iminostilbenes, undetermined, T42.1X5 — Adverse effect of iminostilbenes, T42.1X6 — Underdosing of iminostilbenes

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.